B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: The CHARGE-AF Consortium of community-based cohort studies

Moritz F. Sinner, Katherine A. Stepas, Carlee B. Moser, Bouwe P. Krijthe, Thor Aspelund, Nona Sotoodehnia, João D. Fontes, A. Cecile J.W. Janssens, Richard A. Kronmal, Jared W. Magnani, Jacqueline C. Witteman, Alanna M. Chamberlain, Steven A. Lubitz, Renate B. Schnabel, Ramachandran S. Vasan, Thomas J. Wang, Sunil K. Agarwal, David D. McManus, Oscar H. Franco, Xiaoyan YinMartin G. Larson, Gregory L. Burke, Lenore J. Launer, Albert Hofman, Daniel Levy, John S. Gottdiener, Stefan Kääb, David Couper, Tamara B. Harris, Brad C. Astor, Christie M. Ballantyne, Ron C. Hoogeveen, Andrew E. Arai, Elsayed Z. Soliman, Patrick T. Ellinor, Bruno H.C. Stricker, Vilmundur Gudnason, Susan R. Heckbert, Michael J. Pencina, Emelia J. Benjamin, Alvaro Alonso

Research output: Contribution to journal › Article › peer-review

138 Scopus citations

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: The CHARGE-AF Consortium of community-based cohort studies

Fingerprint

Medicine & Life Sciences